Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
Blis Technologies Ltd
of NEW ZEALAND
(2020
sales of 10.64 million New Zealand Dollars [US$7.63 million]
),
Noxopharm Ltd
(8.34 million Australian Dollars [US$6.43 million]
of which 100%
was Clinical development), and
AFT Pharmaceuticals Ltd
which is
based in NEW ZEALAND
(105.60 million New Zealand Dollars [US$75.75 million]
of which 58%
was Australia).
Sales Analysis.
Probiotec Limited reported sales of A$107.22 million (US$82.67 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 35.6%
versus 2019, when the company's sales were A$79.09 million.
This was the third consecutive year of growth at Probiotec Limited.